Clinical and genomic characterization of ERBB2-altered gallbladder cancer.

被引:0
|
作者
Mondaca, Sebastian
Schultz, Nikolaus
Roa, Juan Carlos
Walch, Henry S.
Sepulveda, Santiago
Harding, James J.
Yaqubie, Amin
Garcia, Patricia
Aguayo, Gloria
Nervi, Bruno
Li, Bob T.
Abou-Alfa, Ghassan K.
机构
[1] Pontificia Univ Catolica Chile, Dept Hematol & Oncol, Fac Med, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dept Pathol, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Santiago, Chile
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[5] Pontificia Univ Catolica Chile, Dept Pathol, Santiago, Chile
[6] Hosp Dr Sotero del Rio, Dept Pathol, Santiago, Chile
[7] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[8] Cornell Univ, Weill Med Coll, New York, NY USA
基金
美国国家卫生研究院;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4114
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Clinical and Genomic Characterization of Esophageal Cancer Brain Metastases
    Yang, D. D.
    Papke, D. J.
    Kang, H.
    Aizer, A. A.
    Lamba, N.
    Kozono, D. E.
    Wee, J. O.
    Enzinger, P.
    Mamon, H. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E65 - E66
  • [42] Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer
    Zhou, Min
    Li, Bingshu
    Liu, Jianfeng
    Hong, Li
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 7341 - 7358
  • [43] ERBB2 amplification in gastric cancer: a genomic insight into ethnic disparities
    Mirza, Muhammad Bilal
    Choi, Jungyoon
    Marincola Smith, Paula
    Baechle, Jordan J.
    Padmanabhan, Chandrasekhar
    Holowatyj, Andreana N.
    Shah, Shailja C.
    Guo, Xingyi
    Idrees, Kamran
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (11): : 1830 - 1833
  • [44] Complex genomic regions associated with ERBB2 amplification in breast cancer
    Tanaka, Hisashi
    Marotta, Michael
    Tubbs, Raymond R.
    CANCER RESEARCH, 2012, 72
  • [45] Clinical utility of comprehensive genomic profiling in patients with unresectable primary liver cancer.
    Ishido, Shun
    Tsuchiya, Kaoru
    Suzuki, Keito
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Matsumoto, Hiroaki
    Nobusawa, Tsubasa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Yasui, Yutaka
    Takahashi, Yuka
    Nakanishi, Hiroyuki
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 542 - 542
  • [46] Integration of radiomic, genomic and clinical data to support decision making for lung cancer.
    Colin, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Identifying unique genomic and clinical characteristics of radiation-associated rectal cancer.
    Omer, Dana M. R.
    Luthra, Anisha
    Thompson, Hannah M.
    Yuval, Jonathan B.
    Romesser, Paul B.
    Paty, Philip B.
    Garcia-Aguilar, Julio
    Sanchez-Vega, Francisco
    CANCER RESEARCH, 2022, 82 (23)
  • [48] Clinical and genomic factors associated with tumor mutational burden (TMB) in prostate cancer.
    Hougen, Helen Y.
    Graf, Ryon
    Quintanilha, Julia C. F. C. F.
    Li, Gerald
    Punnen, Sanoj
    Mahal, Brandon A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [49] Patterns of genomic instability differentiate clinical outcomes in patients with invasive breast cancer.
    Ellsworth, R. E.
    Becker, T. E.
    Ellsworth, D. L.
    Love, B.
    Hooke, J. A.
    Shriver, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 545S - 545S
  • [50] Altered glycosylation and processing of MUC2 apomucin in colon cancer.
    Hong, JC
    Kwan, J
    Gum, JR
    Sleisenger, MH
    Kim, YS
    GASTROENTEROLOGY, 1997, 112 (04) : A579 - A579